PLXS

Business Context and Reporting Period

Plexus Corp. filed its Form 10-Q for the quarter ended December 31, 2002. The company provides product realization services, including design, manufacturing, and testing, to original equipment manufacturers (OEMs) in the networking, medical, industrial, computer, and transportation sectors. The company operates in one business segment across North America, Europe, and Asia.

Key Financial Metrics

Note: The Net Loss for Q1 2003 includes a one-time cumulative effect of a change in accounting for goodwill of $23.5 million (net of tax) and restructuring costs of $31.8 million.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 3% year-over-year, driven partially by the acquisition of MCMS, Inc. assets (contributing ~$18 million or 9% of sales), offsetting a slowdown in the networking and industrial sectors.
• Profitability Decline: Operating loss widened significantly from $2.6 million to $33.1 million. This was primarily due to $31.8 million in restructuring charges and the adoption of SFAS No. 142, which resulted in a $28.2 million goodwill impairment charge recorded as a cumulative effect of accounting change.
• Cash Flow Reversal: Operating cash flow swung from a positive $39.2 million in the prior year to a negative $3.1 million, driven by increased inventory levels, higher deferred taxes, and the net loss.
• Debt Facility Termination: The company terminated its $250 million unsecured revolving credit facility on December 26, 2002, due to anticipated noncompliance with covenants resulting from restructuring costs. No amounts were outstanding at termination.

Guidance, Outlook, and Risks

• Outlook: Management expects second-quarter sales to range between $190 million and $200 million, dependent on actual order levels. Capital expenditures for fiscal 2003 are estimated at $28 million to $32 million.
• Restructuring: Significant actions include the planned closure of the San Diego, California facility (phasing out by June 2003), consolidation of leased facilities, and workforce reductions affecting approximately 500 employees (400 announced in Dec 2002, 100 previously announced).
• Liquidity: Despite the termination of the credit facility, management believes cash, short-term investments, and leasing capabilities are sufficient to meet working capital needs through fiscal 2003. The company is seeking to negotiate a replacement credit facility.
• Risks: Key risks include continued weakness in the electronics industry, high customer concentration (top 10 customers represent 57% of sales), inventory obsolescence in turnkey manufacturing, and the potential inability to secure new financing on favorable terms.

Investor Verification Checklist

• Goodwill Impairment: Verify the details of the $28.2 million transitional impairment charge under SFAS No. 142 and the $5.6 million impairment related to the San Diego facility closure.
• Restructuring Execution: Monitor the progress of the San Diego facility closure and the associated cash outflows for severance and lease exit costs ($15.4 million accrued as of Dec 31, 2002).
• Financing Status: Confirm the status of negotiations for a replacement credit facility to ensure liquidity remains adequate beyond fiscal 2003.
• Customer Concentration: Assess the stability of relationships with top customers (GE and Siemens Medical Systems), which accounted for 24% of sales combined.
• Inventory Levels: Review inventory turnover trends, which declined to 7.7 turns, and the risk of obsolescence given the turnkey business model.